Fig. 2
From: Inhibition LC3B can increase chemosensitivity of ovarian cancer cells
Knockdown LC3B in ovarian cancer cells enhance sensitive of tumor cell to cisplatin. a–c Western blot and statistical analysis of LC3B, Atg7, MDR1 and EpCAM expression in ovarian cancer cells. **p < 0.01, ***p < 0.001. d Cell viability was assessed by CCK-8 in LC3B- group and control group. e–g The level of cleaved-caspase 3, caspase 6 and caspase 9 expression in ovarian cancer cells was measured by western blotting assay and statistical analysis. *p < 0.05, **p < 0.01, ***p < 0.001